🔎 Trials Near Me

ホーム › 肺疾患 › ミシガン州

ミシガン州における肺疾患の臨床試験

ミシガン州内の拠点で、肺疾患に関する17件の研究が参加者を募集しています。

ミシガン州内の都市

公式研究テキスト(英語)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Detroit
  • Research Site, Royal Oak
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05624450

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Revival Research Institute, LLC, Dearborn
  • Henry Ford St. John Hospital, Grosse Pointe Woods
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • University of Michigan, Ann Arbor
  • Henry Ford Hospital, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Revive Research Institute, Inc., Southfield
被験者募集中第2相
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245

American Lung Association (ALA) Lung Health Cohort

  • University of Michigan, Ann Arbor
被験者募集中観察研究健康なボランティア歓迎
25歳〜35歳 · 全性別 · 2026/09/23更新 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • North Ingalls Building, Ann Arbor
  • University of Michigan, Ann Arbor
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/22更新 · NCT06977581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Michigan, Ann Arbor
  • The Cancer & Hematology Centers, Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of Michigan, Ann Arbor
  • Henry Ford Health, Detroit
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Ann Arbor
  • Clinical Research Site, Detroit
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183

Deep Functional Phenotyping of the ALA Lung Health Cohort

  • University of Michigan, Ann Arbor
被験者募集中観察研究健康なボランティア歓迎
25歳〜35歳 · 全性別 · 2026/07/17更新 · NCT06177717

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • Karmanos Cancer Institute, Detroit
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/06/26更新 · NCT04614103

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

  • University of Michigan, Ann Arbor
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/10更新 · NCT05922761

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
被験者募集中
18歳以上 · 全性別 · 2026/02/19更新 · NCT02984761

Supporting Evidence-based Responses to Emotional Needs in Emphysema

  • Henry Ford Health System, Detroit
被験者募集中
18歳以上 · 全性別 · 2026/01/30更新 · NCT06600126

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Henry Ford Cancer Institute, Detroit
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/15更新 · NCT06619561

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

  • University of Michigan, Ann Arbor
被験者募集中第3相
18歳以上 · 全性別 · 2024/07/12更新 · NCT02735707

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。